FDA warning letter · #730095
Maximus: What the FDA Letter Means for What You Pay
Legal name: Maximus Health, Inc.
Primary source
Read the original letter on fda.gov →
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026
What FDA cited
Read the full letter →Quoted verbatim from the FDA letter dated
“Violations were identified and documented during a review of Maximus' website, https://www.maximustribe.com, FDA Establishment Identifier (FEI) 3032037948, in May 2026. FDA observed that your website offers compounded drug products, including semaglutide and tirzepatide products.”
“1. The following claims concerning compounded semaglutide and tirzepatide products appear on your website: "Clinically studied ingredients." "Clinically studied to help patients…." "Proven to lose weight effectively" Compounded drug products are not FDA-approved. Your claims represent that the compounded drug products you offer have been FDA-approved or otherwise evaluated for safety and effectiveness when they have not.”
“2. Your website claims that the compounded drug products it offers are sourced from "FDA approved pharmacies." Compounding facilities, including pharmacies and outsourcing facilities, are not "FDA-approved" or "FDA-licensed" entities. The FD&C Act does not establish an "FDA-approved" or "FDA-licensed" designation for pharmacies or outsourcing facilities.”
Is Maximus still operating?
maximustribe.com returned a live storefront when we checked in August 2026, still operating under the Maximus name.
What this means for what you pay
Two distinct claims got flagged here, and they cut differently: "clinically studied" / "proven to lose weight effectively" is the same overstated-efficacy pattern in the other letters on this page, but "sourced from FDA approved pharmacies" is a step further — FDA said there is no such designation at all, for any pharmacy. If a provider's marketing leans on "FDA-approved pharmacy" language, that phrase itself doesn't mean what it sounds like it means.
Has Maximus responded?
As of , FDA’s public tracking for this letter does not show a logged company response. Companies are not required to make a response public, and FDA does not always update this field promptly — this is not evidence Maximus failed to respond.
Sources
Other letters in this index
- Ezra — June 2026
- MEDVi — February 2026
- Strut — February 2026
- Hims — September 2025
- Hers — September 2025
Editorial disclaimer: An FDA warning letter is a public regulatory communication stating the agency's view. It is not a recall, a fine, a criminal charge, an injunction, or a finding that a company has broken the law.